These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2427822)

  • 21. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
    Dlohozková N; Metys J; Valchár M; Soucek R
    Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
    [No Abstract]   [Full Text] [Related]  

  • 22. Sumatriptan-induced saphenous venoconstriction in the anaesthetized dog through 5-HT1-like receptor activation.
    Drieu la Rochelle C; O'Connor SE
    Br J Pharmacol; 1995 Oct; 116(4):2207-12. PubMed ID: 8564250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for two populations of 5-hydroxytryptamine receptors in dog basilar artery.
    Frenken M
    J Pharmacol Exp Ther; 1989 Jul; 250(1):379-87. PubMed ID: 2545865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.
    Müller-Schweinitzer E
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1455-60. PubMed ID: 2127899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of local anaesthetics on responses of human saphenous vein and bovine coronary artery to neurotransmitters, acetylcholine, noradrenaline and 5-hydroxytryptamine.
    Wali FA
    Gen Pharmacol; 1986; 17(4):405-11. PubMed ID: 2875920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery.
    Fozard JR
    Eur J Pharmacol; 1976 Mar; 36(1):127-139. PubMed ID: 1261590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actions of serotonin antagonists on dog coronary artery.
    Brazenor RM; Angus JA
    Eur J Pharmacol; 1982 Jul; 81(4):569-76. PubMed ID: 6126378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin-induced vasoconstriction in the perfused canine femoral artery can be blocked in vivo by ketanserin.
    Meschig R; Breuer J; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S56-9. PubMed ID: 2412060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.
    Nishimura Y
    Br J Pharmacol; 1996 Mar; 117(6):1325-1333. PubMed ID: 8882632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins.
    Curro FA; Greenberg S; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1978 Dec; 207(3):936-49. PubMed ID: 215746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-(2-Aminoethyl)-quinoline (D-1997): a novel agonist at 5-hydroxytryptamine1-like receptors in the canine basilar artery.
    Terrón JA; López-Muñoz FJ; Hong E; Villalón CM
    Arch Int Pharmacodyn Ther; 1994; 327(1):56-68. PubMed ID: 7944828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoconstrictor mechanism of 5-hydroxytryptamine in isolated and perfused canine basilar arteries.
    Tsuji T; Chiba S
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):111-22. PubMed ID: 3592852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein.
    Feniuk W; Humphrey PP; Watts AD
    Br J Pharmacol; 1979 Oct; 67(2):247-54. PubMed ID: 497528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of doxepin on isolated basilar and saphenous artery rings of rabbits].
    Qi M; Hu XJ; Lü AG; Ke J; Zhang GQ
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):572-4. PubMed ID: 10437150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative stimulus properties of pizotifen maleate (BC105): a putative serotonin antagonist.
    Minnema DJ; Hendry JS; Rosecrans JA
    Psychopharmacology (Berl); 1984; 83(2):200-4. PubMed ID: 6431474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML; Schenck KW; Hemrick-Luecke SH
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor.
    Gupta P; Scatchard J; Napier C; McHarg A; Wallis R
    Eur J Pharmacol; 1999 Feb; 367(2-3):283-90. PubMed ID: 10079003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.
    Conn PJ; Sanders-Bush E
    Neuropharmacology; 1984 Aug; 23(8):993-6. PubMed ID: 6483122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An examination of 5-hydroxytryptamine receptors in human saphenous vein.
    Docherty JR; Hyland L
    Br J Pharmacol; 1986 Sep; 89(1):77-81. PubMed ID: 3801780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.